Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Influenza Treatment Market to reach USD 6.41 billion by the end of 2030.

Global Influenza Treatment Market Size study & Forecast, by Treatment (Peramivir, Zanamivir, Baloxavir Marboxil, Oseltamivir Phosphate, Others) by Route of Administration (Oral, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2023-2030

Product Code: HLSDT-55263721
Publish Date: 10-01-2024
Page: 200

Global Influenza Treatment Market is valued approximately USD 5.84 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.18% over the forecast period 2023-2030. Influenza treatment refers to the therapeutic interventions employed to alleviate the symptoms and complications associated with influenza, a highly contagious respiratory viral infection commonly known as the flu. The primary goals of influenza treatment are to reduce the severity and duration of symptoms, prevent complications, and limit the spread of the virus. The Influenza Treatment market is expanding because of factors such as increased prevalence of contagious respiratory illness, emerging prevalence of seasonal flu and rising drug approval activities.

As per the CDC, the impact of influenza in the United States is substantial, with an estimated 27 to 54 million cases, 300,000 to 650,000 hospitalizations, and 19,000 to 58,000 deaths annually between 2022 and 2023. Preliminary data also reveals around 9 million symptomatic cases, 4 million medical visits, 100,000 hospitalizations, and 5,000 deaths from 2021 to 2022. These figures underscore the significant public health challenge posed by influenza, emphasizing the need for effective preventive measures and treatments to mitigate its impact on individuals and healthcare systems. Thus rising prevalence of seasonal flu is driving the market growth. In addition, rising investment in research and development activities and increased public awareness about the severity of influenza is creating new opportunities for the market growth. However, the high cost of Influenza Treatment stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Influenza Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market players, rising disease prevalence, rising drug development activities in the region. Asia Pacific is expected to grow at a fastest rate during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for durg development, rising healthcare expenditure, and active participation of government and in the market space.

Major market player included in this report are:
NATCO Pharma Limited
Novartis AG
F. Hoffmann-La Roche Ltd
BioCryst Pharmaceuticals, Inc.
Sanofi
GSK plc.
Viatris Inc. (MYLAN)
Teva Pharmaceutical Industries Ltd.
Daiichi Sankyo Company, Limited.
AstraZeneca

Recent Developments in the Market:
Ø In July 2023, Shionogi & Co., Ltd. has disclosed the submission of a supplemental New Drug Application (sNDA) for Xofluza. This application pertains to the pediatric population, specifically for children aged 5 to 12 years, and seeks approval for the use of Xofluza in both post-exposure prophylaxis and the treatment of influenza virus infections.
Ø In April 2023, Nanjing Zenshine Pharmaceuticals revealed positive outcomes from the phase II trials of ZX-7101A, specifically designed to address acute uncomplicated influenza in adults

Global Influenza Treatment Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Treatment, Rout of Administration, Distribution Channel, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:
Peramivir
Zanamivir
Baloxavir Marboxil
Oseltamivir Phosphate
Others

By Route of Administration:
Oral
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Influenza Treatment Market, by region, 2020-2030 (USD Billion)
1.2.2. Influenza Treatment Market, by Treatment, 2020-2030 (USD Billion)
1.2.3. Influenza Treatment Market, by Route of Administration, 2020-2030 (USD Billion)
1.2.4. Influenza Treatment Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Influenza Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Influenza Treatment Market Dynamics
3.1. Influenza Treatment Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increased prevalence of contagious respiratory illness
3.1.1.2. Emerging prevalence of seasonal flu
3.1.1.3. Rising drug approval activities
3.1.2. Market Challenges
3.1.2.1. High Cost of Influenza Treatment
3.1.2.2. Stringent regulatory processes and delays in drug approvals
3.1.3. Market Opportunities
3.1.3.1. Rising investment in research and development activities
3.1.3.2. Increased public awareness about the severity of influenza
Chapter 4. Global Influenza Treatment Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Influenza Treatment Market, by Treatment
5.1. Market Snapshot
5.2. Global Influenza Treatment Market by Treatment, Performance – Potential Analysis
5.3. Global Influenza Treatment Market Estimates & Forecasts by Treatment 2020-2030 (USD Billion)
5.4. Influenza Treatment Market, Sub Segment Analysis
5.4.1. Peramivir
5.4.2. Zanamivir
5.4.3. Baloxavir Marboxil
5.4.4. Oseltamivir Phosphate
5.4.5. Others
Chapter 6. Global Influenza Treatment Market, by Route of Administration
6.1. Market Snapshot
6.2. Global Influenza Treatment Market by Route of Administration, Performance – Potential Analysis
6.3. Global Influenza Treatment Market Estimates & Forecasts by Route of Administration 2020-2030 (USD Billion)
6.4. Influenza Treatment Market, Sub Segment Analysis
6.4.1. Oral
6.4.2. Others
Chapter 7. Global Influenza Treatment Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Influenza Treatment Market by Distribution Channel, Performance – Potential Analysis
7.3. Global Influenza Treatment Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Influenza Treatment Market, Sub Segment Analysis
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Influenza Treatment Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Influenza Treatment Market, Regional Market Snapshot
8.4. North America Influenza Treatment Market
8.4.1. U.S. Influenza Treatment Market
8.4.1.1. Treatment breakdown estimates & forecasts, 2020-2030
8.4.1.2. Route of Administration breakdown estimates & forecasts, 2020-2030
8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Influenza Treatment Market
8.5. Europe Influenza Treatment Market Snapshot
8.5.1. U.K. Influenza Treatment Market
8.5.2. Germany Influenza Treatment Market
8.5.3. France Influenza Treatment Market
8.5.4. Spain Influenza Treatment Market
8.5.5. Italy Influenza Treatment Market
8.5.6. Rest of Europe Influenza Treatment Market
8.6. Asia-Pacific Influenza Treatment Market Snapshot
8.6.1. China Influenza Treatment Market
8.6.2. India Influenza Treatment Market
8.6.3. Japan Influenza Treatment Market
8.6.4. Australia Influenza Treatment Market
8.6.5. South Korea Influenza Treatment Market
8.6.6. Rest of Asia Pacific Influenza Treatment Market
8.7. Latin America Influenza Treatment Market Snapshot
8.7.1. Brazil Influenza Treatment Market
8.7.2. Mexico Influenza Treatment Market
8.8. Middle East & Africa Influenza Treatment Market
8.8.1. Saudi Arabia Influenza Treatment Market
8.8.2. South Africa Influenza Treatment Market
8.8.3. Rest of Middle East & Africa Influenza Treatment Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. NATCO Pharma Limited
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Novartis AG
9.3.3. F. Hoffmann-La Roche Ltd
9.3.4. BioCryst Pharmaceuticals, Inc.
9.3.5. Sanofi S.A
9.3.6. GSK plc.
9.3.7. Viatris Inc. (MYLAN)
9.3.8. Teva Pharmaceutical Industries Ltd.
9.3.9. Daiichi Sankyo Company, Limited.
9.3.10. AstraZeneca
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now